Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03241810 |
|---|---|
| Brief Title: | Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer (SHERBOC) |
| First Submitted : | August 2, 2017 |
| First Submitted that Met QC Criteria : | August 7, 2017 |
| First Posted : | August 8, 2017 |
| Results First Submitted : | July 20, 2020 |
| Results First Submitted that Met QC Criteria : | August 20, 2020 |
| Results First Posted : | September 2, 2020 |
| Last Update Submitted that Met QC Criteria : | August 20, 2020 |
| Last Update Posted : | September 2, 2020 |